Publications

5674 Results

A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for malanoma

Authors
JM Kirkwood;J Manola;VK Sondak;MS Ernstoff;U Rao
Journal / Conference
Clinical Cancer Research 10(5):1680-1677
Year
2004
Research Committee(s)
Melanoma

Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors

Authors
S Chang;W Seiferheld;W Curran;R Share;J Atkins;A Choucair;J Kresl;L Thoron;G Cairncross;J Bahary;C Dolinskas;D Louis;P Bushunow;J Buckner;G Barger;M Mehta
Journal / Conference
International Journal of Radiation Oncology Biology and Physics 59(4):1122-1126
Year
2004
Research Committee(s)
Brain
Study Number(s)
R9813

Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis PMID:15067027

Authors
LL Gunderson;DJ Sargent;TE Tepper;N Wolmark;MJ O'Connell;M Begovic;C Allmer;L Colangelo;SR Smalley;DG Haller;JA Martenson;RJ Mayer;TA Rich;JA Ajani;JS MacDonald;CG Willett;RM Goldberg
Journal / Conference
Journal of Clinical Oncology 22(10):1773-1775
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Intergroup 0144: A phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): mature outcome results and pelvic failure analysis

Authors
S Smalley;J Benedetti;S Williamson;J Robertson;B Fisher;J Martenson;A Benson;R Mayer;C Cripps;N Estes;J Macdonald
Journal / Conference
Proceedings of American Society for Therapeutic Radiology and Oncology, p. S137, abst. #14
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study

Authors
LL Hughes;RJ Gray;LJ Solin;S Martino;D Tripathy;JN Ingle;WC Wood
Journal / Conference
Cancer 101(5):969-972
Year
2004
Research Committee(s)
Breast
Study Number(s)
SWOG-9347 (INT-0142) (E3193)

O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas.

Authors
SC Schold;D Kokkinakis;S Chang;M Berger;K Hess;D Schiff;HI Robins;M Mehta;KL Fink;RL Davis;M Prados
Journal / Conference
Neuro-Oncology Jan;6(1):28-32
Year
2004
Research Committee(s)
Brain
PMID
PMID14769137
PMC
PMC1871964

Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer

Authors
IC Henderson;DA Berry;GD Demetri;CT Cirrincione;L Goldstein;S Martino;JN Ingle;MR Cooper;DF Hayes;KH Tkaczuk;G Fleming;JF Holland;DB Duggan;JT Carpenter;E Frei, III;RL Schilsky;WC Wood;HB Muss;L Norton
Journal / Conference
Journal of Clinical Oncology 21(6):976-983
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

A phase II study of 13-cis retinoic acid plus interferon a-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893)

Authors
RT Skeel;J Huang;J Manola;G Wilding;R Dreicer;P Walker;F Muggia;ED Crawford;JP Dutcher;PJ Loehrer
Journal / Conference
Cancer Investigation 21(1):41-46
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9403 (E3893)

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes 20 year results of a Southwest Oncology Group study

Authors
SE Rivkin;S Green;D Lew;JJ Costanzi;JW Athens;CK Osborne;CB Vaughn;S Martino
Journal / Conference
Cancer 97(1):21-29
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: and Intergroup trial (E1193)

Authors
GW Sledge;D Neuberg;P Bernardo;JN Ingle;S Martino;EK Rowinsky;WC Wood
Journal / Conference
Journal of Clinical Oncology 21(4):588-592
Year
2003
Research Committee(s)
Breast